Form 4: Monopar Therapeutics CFO Kim R. Tsuchimoto Reports Stock Transactions
SEC Form 4 Filing
Kim R. Tsuchimoto, CFO of Monopar Therapeutics, reports the vesting and settlement of restricted stock units resulting in the acquisition and disposal of common stock.
Summary
- On March 31, 2024, Kim R. Tsuchimoto, the Chief Financial Officer of Monopar Therapeutics, reported transactions involving the company's stock.
- These transactions involved the vesting and settlement of restricted stock units (RSUs).
- Specifically, 9,956 shares were acquired upon the vesting of RSUs.
- Additionally, 4,082 shares were withheld by the issuer to cover withholding taxes related to the vesting of these RSUs at a price of $0.681.
- Following these transactions, Tsuchimoto directly owns 50,470 shares of Monopar Therapeutics.
- Tsuchimoto also holds 84,369 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions, and it doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The vesting of RSUs and subsequent stock transactions can have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| January 26, 2021 | Reporting person was granted 19,536 restricted stock units, vesting 6/48ths (2,442 shares) on June 30, 2021, and 3/48ths (1,221 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2024. |
| February 2, 2022 | Reporting person was granted 61,532 restricted stock units, vesting 6/48ths (7,692 shares) on June 30, 2022, and 3/48ths (3,846 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2025. |
| February 1, 2023 | Reporting person was granted 78,234 restricted stock units, vesting 6/48ths (9,779 shares) on June 30, 2023, and 3/48ths (4,890 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. |
| March 31, 2024 | Date of the reported transactions: vesting of RSUs and withholding of shares for taxes. |
| April 02, 2024 | Date of signature for the Form 4 filing. |
| December 31, 2024 | Date that the 19,536 restricted stock units granted on January 26, 2021 are fully vested. |
| December 31, 2025 | Date that the 61,532 restricted stock units granted on February 2, 2022 are fully vested. |
| December 31, 2026 | Date that the 78,234 restricted stock units granted on February 1, 2023 are fully vested. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.